Answers are grounded in this paper and cite their sources.
Molecular docking analysis reveals stigmasterol binds similarly to estradiol at ER-α receptors, suggesting therapeutic potential.
Molecular docking studies of stigmasterol (test ligand) and estradiol (control ligand) against the ER-α receptor were performed using PyRx software. This study aims to determine the interaction between stigmasterol ligands and ER-α receptors by the molecular docking method using PyRx. The study results show that stigmasterol and estradiol have the same binding energy value of -7.3 kcal/mol. The stigmasterol compound could therefore be used as a candidate for breast cancer drugs.
No takes yet. Share an insight, caveat, or question.
Amir et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: